PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL)

Historical Holders from Q1 2024 to Q3 2025

Symbol
DTIL on Nasdaq
Type / Class
Equity / Common Stock, par value $0.000005 per share
Shares outstanding
11,847,682
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
4,649,562
Holdings value
$25,664,758
% of all portfolios
0%
Number of holders
54
Number of buys
25
Number of sells
-17
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Readout Capital, LP 9.4% +5.6% $4,980,934 +$829,645 1,119,311 +20% Matthew Smith 30 Jun 2025
Bleichroeder LP 9.69% $4,783,750 1,075,000 Bleichroeder LP 30 Jun 2025
Lynx1 Capital Management LP 8.8% -11.9% $5,755,026 +$1,526,501 1,042,596 +36.1% LYNX1 CAPITAL MANAGEMENT LP 30 Sep 2025
TANG CAPITAL MANAGEMENT LLC 6.4% $3,588,860 673,332 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
NOVARTIS PHARMA AG 3.7% -34% $1,840,435 413,581 0% Novartis Pharma AG 30 Jun 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 3.7% $2,165,312 406,250 Highbridge Capital Management, LLC 31 Mar 2025
Weinstein Benjamin 5.2% $2,107,956 395,489 Weinstein Benjamin 18 Mar 2025

Institutional Holders of PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 4,649,562 $25,664,758 +$1,234,800 $5.52 54
2025 Q2 4,437,938 $18,638,020 +$2,152,791 $4.2 51
2025 Q1 3,786,321 $18,062,451 +$340,769 $4.77 47
2024 Q4 3,859,340 $14,708,103 -$4,075,765 $3.81 51
2024 Q3 3,323,629 $29,812,914 +$1,425,206 $8.96 50
2024 Q2 3,161,323 $30,774,875 -$108,215 $9.73 45
2024 Q1 3,155,622 $42,757,614 +$42,755,553 $13.56 40